Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Akan Otu"'
Autor:
Dimie Ogoina, Garba Iliyasu, Vivian Kwaghe, Akan Otu, Iorhen Ephram Akase, Olukemi Adekanmbi, Dalhat Mahmood, Micheal Iroezindu, Shamsudin Aliyu, Abisoye Sunday Oyeyemi, Stella Rotifa, Mukhtar Abdulmajid Adeiza, Uche Sonny Unigwe, Juliet Ijeoma Mmerem, Farouq Muhammad Dayyab, Zaiyad Garba Habib, Daniel Otokpa, Emmanuel Effa, Abdulrazaq Garba Habib
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 10, Iss 1, Pp 1-17 (2021)
Abstract Background As part of the Global Action Plan against antimicrobial resistance (AMR), countries are required to generate local evidence to inform context-specific implementation of national action plans against AMR (NAPAR). We aimed to evalua
Externí odkaz:
https://doaj.org/article/44472d76354c49d0a294ff3fef5e7aa5
Publikováno v:
Antimicrob Agents Chemother
Kosmidis, C, Otu, A, Moore, C B, Richardson, M & Rautemaa-Richardson, R 2020, ' Isavuconazole therapeutic drug monitoring during long-term treatment for chronic pulmonary aspergillosis ', Antimicrobial Agents and Chemotherapy, vol. 65, no. 1, e01511-20 . https://doi.org/10.1128/AAC.01511-20
Kosmidis, C, Otu, A, Moore, C B, Richardson, M & Rautemaa-Richardson, R 2020, ' Isavuconazole therapeutic drug monitoring during long-term treatment for chronic pulmonary aspergillosis ', Antimicrobial Agents and Chemotherapy, vol. 65, no. 1, e01511-20 . https://doi.org/10.1128/AAC.01511-20
Isavuconazole is the newest triazole antifungal, and it displays a favorable pharmacokinetic and safety profile. Less is known about its long-term use in immunocompetent hosts. We performed a retrospective service evaluation of isavuconazole therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d0861a3153d89486d88b4f28e7c380b
https://pubmed.ncbi.nlm.nih.gov/33077653
https://pubmed.ncbi.nlm.nih.gov/33077653